mRNA Cancer Vaccines: A New Approach to Cancer Treatment

Unlike the care offered in the past few decades, today’s approach to treating cancer has become even more advanced. Modern medical specialists continue making strides in this direction as part of their work on new research projects. In addition to applying more conventional means, scientists investigate novel methods that include mRNA vaccines. These therapeutic tools represent a relatively new approach to treating diseases.

Although many people associate the term “vaccine” with prevention against a specific health condition, in the case of cancer, mRNA vaccines play quite another role. Contrary to what is often believed, such vaccines do not protect people against tumor formation. Instead, these treatments target existing forms of this health problem and are used in cancer therapy rather than its prevention.

Messenger ribonucleic acid is present in all living things by definition. As part of a natural process, it contains information about proteins to produce in accordance with DNA data. At present, artificial mRNA molecules are produced for medical purposes. They carry codes
necessary to instruct a cell’s machinery to produce certain proteins. Synthetic mRNA does not lead to permanent changes in human cells; however, it allows controlling a specific organismal function.

Inducing immunity towards tumors is one of the objectives of mRNA vaccine technology. While derived from healthy cells, tumor cells sometimes evade recognition by the immune system. This occurs since the immune system does not always recognize the cells as harmful. In order to counteract the problem, mRNA vaccines have been developed which enable the immune system to target certain proteins associated with the cancer cells.

The mRNA once introduced into cells enables them to synthesize cancer proteins. This means that the cells will be detected by the immune system and consequently be recognized. With time, the defensive strategies will start responding to those cells carrying the same proteins hence identifying them as hazardous.

What differentiates this kind of technology from other approaches used is the individuality of mRNA cancer vaccines. With a sample taken from a particular patient, a unique vaccine against their tumor will be developed for personal consumption. According to the U.S. National Cancer Institute, these personalized options can be created in several months.

There are several advantages of mRNA cancer vaccines that have attracted scientists’ attention. For example, while chemotherapy targets both diseased and healthy cells, new technologies intend to target cancer only, sparing the rest. Moreover, after collecting the necessary information, scientists believe that the technique will allow quick modifications in the designs in comparison to conventional techniques.

Nevertheless, there is one critical aspect that should be taken into account. In general, studies on mRNA cancer vaccines are still being conducted. The great majority of them are currently being tested under clinical conditions. Nevertheless, the results of preliminary experiments were encouraging for certain types of tumors, such as melanoma or pancreatic cancer. The effectiveness of the vaccine for various people is still under investigation.

On the other hand, several problems need to be addressed. First, different tumors react differently to treatment, thus affecting the efficiency of the process. Secondly, immune-based treatments might not produce sufficient reactions in patients. Finally, financial costs should not be overlooked, as vaccines are developed individually.

As for the future, the use of mRNA-based cancer vaccines represents a change in the methods used to develop new treatments. Since such a vaccine may make the body better able to recognize malignant cells, the use of personalized therapy would be expected in the future. Even if further studies are carried out, it is likely that such vaccines may become part of future treatments

Bibliography

Cansu Düzgün